Isabel Weigand
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Pituitary Gland Disorders and Treatments
- Hormonal Regulation and Hypertension
Papers in
-
- Cancer, Hypoxia, and Metabolism 13
- Cancer, Lipids, and Metabolism 4
- Surgery 19
- Adrenal and Paraganglionic Tumors 19
- Co-authors
- Martin Faßnacht (22 shared papers)Silviu Sbiera (20 shared papers)Matthias Kroiß (17 shared papers)Cristina Lucia Ronchi (12 shared papers)Timo Deutschbein (5 shared papers)Andreas Rosenwald (5 shared papers)Barbara Altieri (6 shared papers)Iuliu Sbiera (4 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (5 papers)European Journal of Endocrinology (3 papers)Frontiers in Endocrinology (2 papers)Endocrinology (2 papers)Cancers (2 papers)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
Isabel Weigand
33 papers receiving 1.3k citations
Isabel Weigand's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 489
- Endocrinology, Diabetes and Metabolism 440
- Genetics 199
- Surgery 555
- Pulmonary and Respiratory Medicine 233
Countries citing papers authored by Isabel Weigand
This map shows the geographic impact of Isabel Weigand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Weigand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Weigand more than expected).
Fields of papers citing papers by Isabel Weigand
This network shows the impact of papers produced by Isabel Weigand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Weigand. The network helps show where Isabel Weigand may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabel Weigand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis Hit paper breakdown → | 2024 | 236 |
| 2 | 2015 | 161 | |
| 3 | 2018 | 95 | |
| 4 | 2016 | 91 | |
| 5 | 2019 | 82 | |
| 6 | 2020 | 75 | |
| 7 | 2016 | 71 | |
| 8 | 2020 | 56 | |
| 9 | 2016 | 48 | |
| 10 | 2019 | 37 | |
| 11 | 2019 | 36 | |
| 12 | 2019 | 35 | |
| 13 | 2016 | 31 | |
| 14 | 2015 | 28 | |
| 15 | 2020 | 27 | |
| 16 | 2020 | 26 | |
| 17 | 2021 | 24 | |
| 18 | 2019 | 23 | |
| 19 | 2020 | 22 | |
| 20 | 2021 | 21 |
About Isabel Weigand
Isabel Weigand is a scholar working on Cancer Research, Surgery, Endocrinology, Diabetes and Metabolism, Genetics and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (19 papers), Cancer, Hypoxia, and Metabolism (13 papers), Pituitary Gland Disorders and Treatments (5 papers), Hormonal Regulation and Hypertension (4 papers), Cancer, Lipids, and Metabolism (4 papers), Glioma Diagnosis and Treatment (3 papers), Mitochondrial Function and Pathology (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (489 citations), Endocrinology, Diabetes and Metabolism (440 citations), Genetics (199 citations), Surgery (555 citations) and Pulmonary and Respiratory Medicine (233 citations). Isabel Weigand has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Martin Faßnacht, Silviu Sbiera, Matthias Kroiß, Cristina Lucia Ronchi, Timo Deutschbein, Andreas Rosenwald, Barbara Altieri, Iuliu Sbiera, Bruno Allolio and Laura-Sophie Landwehr. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, European Journal of Endocrinology, Frontiers in Endocrinology, Endocrinology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.